What Is Context Therapeutics Inc. (CNTX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Context Therapeutics Inc. presents a highly debated valuation profile at its current price of $0.63. The composite intrinsic value is estimated at $0.68 (+7.7% average upside), masking a wide model spread between the 3 bullish models and 3 bearish models. Model dispersion is worth noting: Sentiment SOTP targets $1.33 (+110.7%), versus ML-RIV at $0.10 (-83.9%). This +194.6% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About CNTX?
6 of 13 models are currently active for CNTX. Of these, 3 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates CNTX's intrinsic value at $0.44, implying -30.1% downside from the current price. See which stocks rank higher →
How Does CNTX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, CNTX ranks #275 by Quality of Company score. CirclFi's QOC score of 4.5/10 evaluates 32 fundamental signals. A score of 4.5 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, Context Therapeutics Inc. operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating CNTX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is CNTX a Value Trap?
CirclFi's Value Trap algorithm assigns CNTX a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for Context Therapeutics Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Context Therapeutics Inc.'s fundamental quality profile registers 4.5/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +194.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CNTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CNTX's 6 active models, average confidence is 30%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad